Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study Academic Article uri icon

Overview

MeSH Major

  • Cardiovascular Diseases
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Somatotypes

abstract

  • In the LIFE study, stratification for classes of body build identified increased risk of cardiovascular mortality in both thin and moderately-to-severely obese individuals. This risk was not attenuated significantly by losartan treatment, nor did it interfere with the greater benefit of losartan-based treatment as opposed to atenolol-based treatment.

publication date

  • April 19, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000161799.91577.0A

PubMed ID

  • 15837945

Additional Document Info

start page

  • 1924

end page

  • 31

volume

  • 111

number

  • 15